Jury Awards Concordia Pharma $730K In False Ad Row
A Virginia federal jury determined Thursday that Method Pharmaceuticals LLC was liable to rival Concordia Pharmaceuticals Inc. for falsely advertising its irritable bowel syndrome medication as a generic substitute for a...To view the full article, register now.
Already a subscriber? Click here to view full article